Publication:
Serum Levels of 25-Hydroxyvitamin D in Chronic Plaque Psoriasis

creativeworkseries.issnISSN 2091-0231 eISSN 2091-167X
dc.contributor.authorJha, Ayush
dc.contributor.authorBasukala, Manisha Singh
dc.contributor.authorShrestha, Rima
dc.contributor.authorDawadi, Roji
dc.date.accessioned2025-10-06T11:06:52Z
dc.date.available2025-10-06T11:06:52Z
dc.date.issued2023
dc.descriptionAuthor Biographies Ayush Jha, KIST Medical College and Teaching Hospital, Lalitpur, Nepal Lecturer,Department of Dermatology, KIST Medical College and Teaching Hospital, Lalitpur, Nepal Manisha Singh Basukala, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal Consultant Dermatologist , Department of Dermatology, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal Rima Shrestha, KIST Medical College and Teaching Hospital, Lalitpur, Nepal Professor , Department of Dermatology, KIST Medical College and Teaching Hospital, Lalitpur, Nepal Roji Dawadi, KIST Medical College and Teaching Hospital, Lalitpur, Nepal Resident ,Department of Dermatology, KIST Medical College and Teaching Hospital, Lalitpur, Nepal
dc.description.abstractAbstract: Background: Psoriasis is an immune mediated inflammatory disease that involves the innate and acquired arm of immunologic system. The regulatory role for vitamin D in immune system is suggested by presence of vitamin D receptors on activated lymphocytes and suppressive or inhibiting effect of 1,25-dihydroxyvitamin D in different autoimmune diseases. Hence, the current proposed study aims to study the 25-hydroxyvitamin D status of patients with psoriasis. Objective: The primary objective of this study was to analyze the 25-hydroxyvitamin D status of patients with chronic plaque psoriasis in comparison to healthy control subjects. Materials and Methods: A comparative cross-sectional study, including forty patients with chronic plaque psoriasis and forty age- and sex-matched control subjects, was conducted from April 2021 to December 2022, at our dermatology department. After informed consent, all patients were subjected to detailed clinical and anthropometric examination. Serum concentration of 25-hydroxyvitamin D was evaluated in chronic plaque psoriasis cases and healthy control subjects. Data was be analyzed as per standard statistical protocol. Results: The mean serum 25-hydroxyvitamin D level in psoriatic group and control group were 18.02 (±SD 9.82) ng/ml and 24.47 (±SD 6.77) ng/ml, respectively. (p=.001) Serum 25-hydroxyvitamin D was negatively correlated with Psoriatic area and severity index (PASI) score (r=-.11). However, this correlation was not significant (p=.493). Conclusion: Serum 25-hydroxyvitamin D levels were significantly lower in psoriatic patients than in control subjects.
dc.identifierhttps://doi.org/10.3126/njdvl.v21i1.52130
dc.identifier.urihttps://hdl.handle.net/20.500.14572/2443
dc.language.isoen_US
dc.publisherSociety of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON)
dc.subjectPsoriasis
dc.subjectPsoriasis area severity index
dc.subject25-hydroxyvitamin D
dc.titleSerum Levels of 25-Hydroxyvitamin D in Chronic Plaque Psoriasis
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage44
oaire.citation.startPage41
relation.isJournalIssueOfPublicationabc0e550-10bd-40cb-bef7-1cea2f469a57
relation.isJournalIssueOfPublication.latestForDiscoveryabc0e550-10bd-40cb-bef7-1cea2f469a57
relation.isJournalOfPublicationb2ab7aab-75b0-4bd1-9ed0-b8a91c68201a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
41-44.pdf
Size:
184.85 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections